DBV Technologies S.A.

DBVT

DBV Technologies S.A.

DBVT

Insider Sentiment (TTM):

Last Purchase:2024-03-08Last Sale:2026-01-29Shares Purchased (TTM):0Shares Sold (TTM):1,294,261

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:4,773,142Shares Outstanding:85,660,570Institutional Ownership Pct.:5.57%

Earnings Market Reaction:

Filing Date:2026-07-16Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	175	229	194	70	103	13	32	46	66	102	141	149
Receivables Net Current	-	-	-	-	-	-	-	-	-	-	0	-
Other Assets Current	27	18	19	19	18	16	12	22	24	18	18	20
Assets Current	202	247	213	89	121	29	44	69	90	120	159	169
Assets Noncurrent
Property Plant And Equipment Net	10	10	10	11	11	11	11	13	13	13	13	13
Operating Lease Right Of Use Asset	6	4	5	6	6	6	6	6	6	7	5	1
Intangible Assets Net Excluding Goodwill	-	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	6	5	6	5	5	5	4	5	5	7	6	6
Assets Noncurrent	21	20	21	22	22	21	21	24	24	26	24	21
Assets	223	266	234	110	143	51	66	93	114	146	183	190
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	39	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liability Current	1	1	1	1	1	1	1	0	0	0	1	2
Accounts Payable Trade Current	12	40	41	40	41	34	22	23	20	18	23	17
Other Liabilities Current	14	11	16	8	8	5	8	8	6	5	9	9
Liabilities Current	54	52	58	49	49	40	31	31	27	26	37	31
Liabilities Noncurrent
Operating Lease Liability Noncurrent	7	5	5	7	7	7	6	7	7	7	5	0
Other Liabilities Noncurrent	-	-	-	-	-	-	-	0	0	0	0	3
Liabilities Noncurrent	9	7	7	8	8	7	7	8	8	8	5	14
Liabilities	63	58	65	58	57	48	38	39	35	34	43	46
Stockholders Equity
Common Stock Value	30	30	24	14	14	12	12	11	11	11	11	11
Additional Paid In Capital	408	626	541	392	392	317	316	316	315	379	377	376
Treasury Stock Value	-	-	-	-	-	-	-	-	-1	-1	-1	-1
Treasury Stock Common Value	-1	-1	-1	-1	-1	-1	-1	-1	-	-	-1	-
Retained Earnings Accumulated Deficit	-270	-441	-393	-348	-102	-313	-286	-263	-233	-266	-239	-228
Accumulated Other Comprehensive Income Loss Net Of…	1	0	0	1	1	1	1	1	1	1	1	1
Stockholders Equity	160	208	169	53	86	3	27	54	79	112	140	144
Liabilities And Stockholders Equity	223	266	234	110	143	51	66	93	114	146	183	190
Common Stock Par Or Stated Value Per Share	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	-	-	0.1	-
Common Stock Shares Authorized	59	59	47	27	27	21	21	19	-	-	19	-
Common Stock Shares Issued	59	59	47	27	27	21	21	19	-	-	19	-
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-13.43%	-26.05%	-30.00%	-9.29%	-	-	-	-	-	-	-	-
2025	-6.66%	4.33%	10.99%	2.04%	-3.06%	72.96%	-11.58%	46.37%	33.63%	5.59%	-2.77%	-13.83%
2024	-17.65%	-41.10%	-31.40%	-2.85%	-21.33%	-25.55%	406.49%	313.64%	463.64%	22.27%	14.07%	21.31%
2023	-	-	-	0.68%	-2.70%	-28.38%	-20.79%	-8.81%	-17.82%	-9.32%	-17.43%	-26.15%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	3.72	4.76	3.67	1.80	2.45	0.72	1.43	2.22	3.29	4.51	4.26	5.38
Quick Ratio	3.72	4.76	3.67	1.80	2.45	0.72	1.43	2.22	3.29	4.51	4.26	5.38
Working Capital	147.60M	194.90M	154.92M	39.40M	71.82M	-11.24M	13.25M	37.85M	62.58M	93.08M	121.58M	137.83M
Leverage & Debt
Debt to Equity	0.39	0.28	0.38	1.09	0.66	16.44	1.40	0.72	0.44	0.31	0.31	0.32
Debt Ratio	0.28	0.22	0.28	0.52	0.40	0.94	0.58	0.42	0.31	0.23	0.23	0.24
Efficiency & Turnover
Asset Turnover TTM	0.03	0.04	0.04	0.05	0.03	0.04	0.03	0.09	0.08	0.08	0.07	0.03
Per Share Metrics
Diluted EPS TTM	-2.03	-1.95	-5.26	-4.57	-4.55	-5.54	-5.87	-5.31	-4.60	-4.13	-3.82	-5.24
Free Cash Flow Per Share TTM	-1.97	-1.77	-4.36	-3.60	-3.30	-4.42	-5.52	-5.65	-5.48	-4.96	-4.22	-4.69
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-3,603.24%	-2,935.08%	-2,609.23%	-2,253.14%	-3,139.04%	-3,234.51%	-2,808.70%	-836.26%	-670.27%	-561.04%	-485.96%	-1,847.68%
Net Profit Margin TTM	-3,564.57%	-2,919.23%	-2,607.29%	-2,241.34%	-3,153.67%	-3,207.48%	-2,744.35%	-815.80%	-639.81%	-532.16%	-462.40%	-1,816.22%
Growth Metrics
Net Revenue Growth (1Y)	27.12%	61.85%	35.77%	-55.37%	-71.89%	-76.28%	-73.61%	125.52%	163.07%	232.61%	224.69%	-38.89%
Net Income Growth (1Y)	43.68%	47.31%	28.99%	22.62%	38.55%	42.97%	56.64%	1.30%	-12.78%	-20.59%	-24.46%	42.54%
EPS Growth (1Y)	-55.43%	-64.71%	-10.36%	-13.78%	-0.91%	33.99%	53.61%	1.16%	-14.45%	-22.41%	-38.55%	39.32%
Valuation Metrics
P/E TTM	-8.08	-10.69	-3.64	-2.19	-2.01	-1.23	-0.53	-0.13	-0.17	-0.36	-0.50	-0.52
P/B TTM	8.87	8.61	3.17	5.18	2.86	48.27	2.19	0.25	0.19	0.26	0.26	0.36
P/S TTM	288.09	311.97	94.95	48.99	63.45	39.49	14.44	1.08	1.12	1.93	2.31	9.42
Market Cap	1.42B	1.79B	535.13M	273.62M	246.36M	139.97M	59.94M	13.47M	15.41M	28.81M	36.26M	52.27M
Enterprise Value	1.25B	1.56B	527.00M	203.79M	143.16M	126.97M	27.49M	-32.97M	-50.81M	-72.71M	-105.11M	-96.87M
Calculated Values
Free Cash Flow TTM	-170.61M	-151.51M	-121.71M	-98.54M	-88.83M	-90.74M	-107.06M	-108.72M	-105.49M	-95.41M	-80.33M	-90.19M
Net Debt	-174.90M	-229.20M	-8.13M	-69.84M	-103.20M	-13.00M	-32.46M	-46.44M	-66.21M	-101.53M	-141.37M	-149.14M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-01-29Sale

Owner: Mohideen, Pharis

Title: Chief Medical Officer

Shares: 534

Price/Share: $4.86

Value: $2,595.24

Shares Owned: 144,995

Relationship: Officer

Ownership: Direct

2025-12-18Sale

Owner: Epic, Bpifrance, Bpifranc…

Title: -

Shares: 1,292,103

Price/Share: $4.19

Value: $5,413,911.57

Shares Owned: 7,303,369

Relationship: Other

Ownership: Indirect

2025-11-21Sale

Owner: Mohideen, Pharis

Title: Chief Medical Officer

Shares: 1,624

Price/Share: $2.77

Value: $4,498.48

Shares Owned: 101,529

Relationship: Officer

Ownership: Direct

2025-07-29Sale

Owner: Mohideen, Pharis

Title: Chief Medical Officer

Shares: 464

Price/Share: $2.22

Value: $1,030.08

Shares Owned: 109,649

Relationship: Officer

Ownership: Direct

2025-05-22Sale

Owner: Mohideen, Pharis

Title: Chief Medical Officer

Shares: 397

Price/Share: $1.84

Value: $730.48

Shares Owned: 110,113

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-01-29	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	534	4.86	$2,595.24	144,995	4
2025-12-18	Epic, Bpifrance, Bpifranc…	Other	-	Indirect	Sale	1,292,103	4.19	$5,413,911.57	7,303,369	4
2025-11-21	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	1,624	2.77	$4,498.48	101,529	4
2025-07-29	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	464	2.22	$1,030.08	109,649	4
2025-05-22	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	397	1.84	$730.48	110,113	4
2025-01-30	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	600	0.85	$510.00	110,510	4
2024-11-25	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	565	0.57	$322.05	111,110	4
2024-11-21	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	2,350	0.54	$1,269.00	112,017	4
2024-07-29	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	1,785	0.98	$1,749.30	79,367	4
2024-05-24	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	660	1.36	$897.60	81,152	4
2024-03-08	Tasse, Daniel	Director,Officer	CHIEF EXECUTIVE OFFICER	Direct	Purchase	17,094	0.83	$14,188.02	17,094	4
2024-02-06	Ndu, Adora	Director	-	Direct	Purchase	1,825	0.89	$1,624.25	1,825	4
2023-11-22	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	2,245	1.74	$3,906.30	82,194	4
2023-08-25	Morris, Timothy E	Director	-	Direct	Purchase	12,000	1.52	$18,240.00	12,000	4
2023-08-01	Soland, Daniel B	Director	-	Direct	Purchase	15,000	1.62	$24,300.00	20,000	4
2023-05-24	Mohideen, Pharis	Officer	Chief Medical Officer	Direct	Sale	469	3.54	$1,660.26	49,439	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

5.57%

Inst. Shares: 4,773,142

Shares Outstanding: 85,660,570

2025-12-31

16.57%

Inst. Shares: 4,625,458

Shares Outstanding: 27,914,852

2025-09-30

5.26%

Inst. Shares: 1,439,027

Shares Outstanding: 27,362,390

2025-06-30

3.93%

Inst. Shares: 1,058,235

Shares Outstanding: 26,895,301

2025-03-31

0.02%

Inst. Shares: 3,891

Shares Outstanding: 20,523,486

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	4,773,142	85,660,570	5.57%
2025-12-31	4,625,458	27,914,852	16.57%
2025-09-30	1,439,027	27,362,390	5.26%
2025-06-30	1,058,235	26,895,301	3.93%
2025-03-31	3,891	20,523,486	0.02%
2024-12-31	36,596	19,399,076	0.19%
2023-09-30	9,525,348	19,215,108	49.57%
2023-06-30	9,847,896	18,864,978	52.20%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

DBV Technologies S.A. (DBVT) — SEC Financial Statements & Analysis

DBV Technologies S.A. (DBVT) is a biological products, (no diagnostic substances) company, incorporated in I0. DBV Technologies S.A. trades on Nasdaq, OTC as: DBVT, DBVTF. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), DBV Technologies S.A. reported a 27.12% year-over-year revenue growth, a Debt-to-Equity ratio of 0.39x, a Price-to-Sales (P/S) ratio of 288.09x (TTM), a Price-to-Book (P/B) ratio of 8.87x (TTM), at a market cap of $1.42B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 27.12%
Debt To Equity: 0.39x
P/S TTM: 288.09x
P/B TTM: 8.87x
Market Cap: $1.42B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is DBV Technologies S.A. in?

DBV Technologies S.A. (DBVT) operates in the Biological Products, (No Diagnostic Substances) industry.

What is DBVT's market cap?

DBV Technologies S.A. (DBVT) has a market capitalization of $1.42B as of 2026-06-30.

What exchange does DBVT trade on?

DBV Technologies S.A. (DBVT) trades on the Nasdaq, OTC.

Where is DBV Technologies S.A. incorporated?

DBV Technologies S.A. is incorporated in France.